John Schroeppel, MD
Orthopaedic Surgery · Kansas City, KSNPI 1134319346
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (28.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Arthrex at 37.9% of the total. Reporting peaked in 2019 at $12,394 and has fallen 96.2% since, to $472 in 2025.
Across 151 payments — averaging $182.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$10K
- Vericel Corporation$8K
- Titan Surgical Group, LLC$6K
- Zimmer Biomet$2K
- Stryker$683
- Smith+Nephew$167
- plus $288 from 5 others
Across 7 payments — averaging $1748.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$12K
What the payments were for
- Consulting fees$5,59520%
- Speaking & faculty fees$3,50013%
- Travel & lodging$7,19626%
- Food & beverage$3,52013%
- Education$7,73828%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 65 | $10,436 |
| Vericel Corporation | 25 | $7,773 |
| Titan Surgical Group, LLC | 14 | $5,920 |
| Zimmer Biomet | 22 | $2,284 |
| Stryker | 7 | $683 |
| Smith+Nephew | 3 | $167 |
| Ferring Pharmaceuticals Inc. | 8 | $132 |
| Vertex | 3 | $68 |
| Fidia Pharma USA Inc. | 2 | $51 |
| Heron Therapeutics, Inc. | 1 | $22 |
| Bioventus LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MACI$7,278
- ROSA$1,359
- IVY AIR$171
- INSPACE$169
- TAPESTRY$161
- VERSITOMIC$149
- CHAMPION SHOULDER INSTRUMENTATION SET$149
- CINCHLOCK SS$149
- Regeneten$105
- ROSA-Knee$104
How this compares
$27,550 in reported general payments places this provider in the 85th percentile of 197 orthopaedic surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 27 | $947 |
| Meloxicam | 65 | $240 |
| Cephalexin | 34 | $40 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Kansas City
- David AndersonKansas City$490K
- Brandon CarlsonKansas City$299K
- Brent WiseKansas City$97K
- Mitchell BirtKansas City$26K
- Spencer FalconKansas City$23K
- Bryan VopatKansas City$22K
- Katie SmeltzerKansas City$19K
- Everett WilkinsonKansas City$12K
- Jacob BrubacherKansas City$11K
- Jacob DeisterTopeka$185K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.